# A Study of SRP-9005 in Limb Girdle Muscular Dystrophy Type 2C/R5 Pediatric and Adult Participants

> **NCT06952686** · PHASE3 · WITHDRAWN · sponsor: **Sarepta Therapeutics, Inc.**

## Conditions studied

- Muscular Dystrophies, Limb-Girdle

## Interventions

- **BIOLOGICAL:** SRP-9005
- **DRUG:** Corticosteroid

## Key facts

- **NCT ID:** NCT06952686
- **Lead sponsor:** Sarepta Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-06-30
- **Primary completion:** 2030-11-30
- **Final completion:** 2032-03-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was Withdrawn per Sponsor decision.
- **Last updated:** 2025-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06952686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06952686, "A Study of SRP-9005 in Limb Girdle Muscular Dystrophy Type 2C/R5 Pediatric and Adult Participants". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06952686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*